Arax Advisory Partners’s 89bio ETNB Stock Holding History

Arax Advisory Partners’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,403	Closed	-$35.3K	–	4222
2025 Q3	$35.3K	Buy	+2,403	New	+$24.5K	﹤0.01%	2004
2025 Q2	–	Sell	-84	Closed	-$611	–	3094
2025 Q1	$611	Hold	84	–	–	﹤0.01%	2497
2024 Q4	$657	Buy	84 +51	+155%	+$420	﹤0.01%	2269
2024 Q3	$245	Hold	33	–	–	﹤0.01%	2497
2024 Q2	$265	Buy	+33	New	+$295	﹤0.01%	2419

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arax Advisory Partners's ETNB Position: Q4 2025 in Review

Arax Advisory Partners sold out of 89bio (ETNB) in Q4 2025, closing a stake of 2,403 shares — an estimated $35.3K sold.

Arax Advisory Partners first reported a position in ETNB in Q2 2024 and held it in 5 quarters. The position peaked at $35.3K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Arax Advisory Partners reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 2,403 89bio shares in Q4 2025, an estimated $35.3K.
Arax Advisory Partners first reported a position in 89bio in Q2 2024 and held it in 5 quarters.
Arax Advisory Partners's 89bio position peaked at $35.3K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.